Care for the Critically Injured Burn Patient | Apply Online

Frequently Asked Questions (FAQs) - Care for the Critically Injured Burn Patient (CCIBP)

1) What is the "Care for the Critically Injured Burn Patient" opportunity?

This is a U.S. Department of Defense (DoD) research funding announcement under the Defense Medical Research and Development Program (DMRDP). It is focused on improving care and outcomes for severely burned patients, with a strong emphasis on needs arising from modern battlefield injuries.

2) What is the main goal of this funding announcement?

The overarching intent is to advance practical, clinically relevant science that can move quickly into real-world use. The program emphasizes translation of knowledge and technology into deployable products and new standards of care that can be used in deployed settings and across Military Health System facilities.

3) Which organizations sponsor and manage this program?

The program is sponsored by the Office of the Assistant Secretary of Defense for Health Affairs through the Defense Health Program Medical Research and Development Office. The Telemedicine and Advanced Technology Research Center (TATRC) manages the application process. The U.S. Army Medical Research Acquisition Activity (USAMRAA) issues the announcement and negotiates and administers the resulting awards.

4) What kinds of projects does the program want to fund?

The announcement is designed to support innovative research and development that strengthens prevention, treatment, rehabilitation, and training related to burn injuries. A clear preference is indicated for work that can influence clinical practice, standardize care across sites, and measurably improve patient outcomes.

5) Is this opportunity focused only on military applications?

While the motivation is military readiness and service member health, the expected benefits are broader. Findings are intended to help both military and civilian burn care communities.

6) What are the priority research areas for this opportunity?

Four priority areas are emphasized:

• Multi-center development and evaluation of checklists to standardize burn care and improve outcomes.
• Multi-center studies of ICU-based rehabilitation, including evaluation of physical and rehabilitation technologies or therapies.
• Device and/or drug development and validation for inhalation lung injury.
• Research on hypertrophic scar formation and therapies to prevent or manage scarring.

7) What does the program mean by "multi-center" work?

The announcement highlights research approaches that involve multiple sites (for example, multiple burn centers). This is especially relevant to the checklist and ICU-based rehabilitation priorities, where standardization and broader evidence generation across sites are central themes.

8) What is meant by developing and evaluating "checklists" for burn care?

The program seeks systems-based interventions, such as checklists, that can reduce variation, prevent errors, and improve outcomes across burn centers. The emphasis is on multi-center development and evaluation, with the goal of standardizing burn care across sites.

9) What is included under the ICU-based rehabilitation priority?

This priority calls for multi-center studies of rehabilitation in the intensive care unit (ICU), including rigorous evaluation of physical and rehabilitation technologies or therapies.

10) What specific outcomes does the program highlight for ICU-based rehabilitation research?

Within the ICU-based rehabilitation priority, the program highlights three connected goals:

• Improve short-term ICU outcomes (for example, reducing ICU length of stay and ventilator days).
• Clarify how rehabilitation affects ICU burn patient pathophysiology.
• Demonstrate whether early ICU interventions translate into long-term functional and quality-of-life gains, including return-to-work or return-to-duty rates.

11) What is the inhalation lung injury priority focused on?

The program supports device and/or drug development and validation for inhalation lung injury, described as a major driver of mortality and complications in severe burn trauma.

12) What is the hypertrophic scarring priority focused on?

The program funds research on hypertrophic scar formation and the development of therapies to prevent or manage scarring. This is tied to long-term recovery, function, and appearance after burn injury.

13) Who is eligible to apply?

The eligible applicant category is listed as unrestricted, meaning any entity may apply as long as it meets any conditions in the full announcement.

14) Does the program encourage participation from military or other federal investigators?

Yes. The opportunity explicitly encourages proposals from investigators within the military services and other federal agencies.

15) Are collaborations encouraged?

Yes. The program encourages multidisciplinary partnerships that can involve academia, industry, the military, the Department of Veterans Affairs, and other federal organizations. This aligns with the emphasis on multi-center studies and accelerating technology transition and clinical adoption.

16) What type of funding mechanism is used?

The announcement supports cooperative agreements and grants under a discretionary funding category for science, technology, and other research and development.

17) How many awards are expected?

The anticipated number of awards is six.

18) What is the total amount of funding available under this solicitation?

The estimated total program funding is $6.6 million.

19) What is the maximum award amount?

The maximum award amount is $1.5 million.

20) Is there a minimum award amount?

No minimum award floor is stated in the provided information.

21) Is cost sharing or matching required?

No. Cost sharing or matching is not required.

22) When was the opportunity posted, and what were the key dates?

The opportunity was posted on October 28, 2011. The application closing date was March 9, 2012. The archive date was April 8, 2012. These dates indicate it was a time-limited FY12 solicitation.

23) What is the funding opportunity number?

The funding opportunity number is W81XWH-12-CCCJPC-CCIBP.

24) What CFDA number is associated with this opportunity?

This opportunity is associated with CFDA 12.420, Military Medical Research and Development.

25) Which agency is listed for this opportunity?

USAMRAA (U.S. Army Medical Research Acquisition Activity) is the listed agency.

26) Who is the point of contact mentioned for access issues?

A point of contact is provided for access issues with the full announcement: Mary Rico, Grants Officer, CCIBP.

27) What does the program mean by "translation" and "deployable" outcomes?

Translation refers to taking promising knowledge and technologies and turning them into deployable products and new standards of care. The announcement stresses solutions that can move quickly into real-world use, including in deployed environments and across Military Health System facilities.

28) What overall theme connects the priority areas?

The priorities reflect an outcomes-oriented approach to burn care, emphasizing standardization across sites, rigorous multi-center evidence generation, and practical advances in critical care, rehabilitation, inhalation injury countermeasures, and scar prevention or treatment.